Toggle navigation
Home
Search
Services
Blog
Contact
About
Pediatric Hydroxyurea Phase III Clinical Trial
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Epigenomic Mechanisms of Heart Failure
Hematopoietic Cell Transplantation for Hematologic Malignancies
FGF-23 Regulation in Chronic Kidney Disease
Noninvasive Evaluation of Coronary Bypass Graft Patency
Age-Related Changes in the Vestibular Labyrinth
Recently added grants:
An investigation of the relationship between toxicant exposures during Gulf War deployment and prodromal Parkinson's disease.
Neurocognitive markers of short-term risk for suicidal behavior in high-risk Veterans
Computational Methods for the Study of American Sign Language Nonmanuals Using Very Large Databases
Imaging Molecular Mechanisms of Tobacco Smoking Withdrawal
Using 'Big Data' and Precision Medicine to Assess and Manage Suicide Risk in U.S. Veterans
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB07159-20-0-1
Application #
7574908
Study Section
Project Start
2000-09-01
Project End
2009-03-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
/ University of Texas Sw Medical Center Dallas
$905,218
NIH 2007
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
Rogers, Zora R. /
$616,542
NIH 2007
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
/
Comments
Be the first to comment on this grant